Nitazoxanide Pharmacokinetic Parameters in Hepatic Impaired Patients
NCT05116826
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
25
Enrollment
INDUSTRY
Sponsor class
Conditions
Moderate Hepatic Impairment
Severe Hepatic Impairment
Liver Diseases
Interventions
DRUG:
Nitazoxanide
Sponsor
Genfit